MDXG (MiMedx Group) Cyclically Adjusted FCF per Share: $0.12 (As of Mar. 2026)


MDXG MiMedx Group Inc MDXG
53 GF Score
Price $4.08
GF Value $6.87
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is MiMedx Group Cyclically Adjusted FCF per Share?

MiMedx Group MDXG +3.04% 53 Cyclically Adjusted FCF per Share is $0.12 as of Mar. 2026. GuruFocus rates MDXG with a GF Score™ of 53/100 and a GF Value™ of $6.87 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

MiMedx Group's adjusted free cash flow per share for the three months ended in Mar. 2026 was $0.009. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.12 for the trailing ten years ended in Mar. 2026.

During the past 12 months, MiMedx Group's average Cyclically Adjusted FCF Growth Rate was 50.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 54.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 29.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of MiMedx Group was 54.20% per year. The lowest was -12.60% per year. And the median was 22.30% per year.

As of today (2026-07-07), MiMedx Group's current stock price is $4.08. MiMedx Group's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $0.12. MiMedx Group's Cyclically Adjusted Price-to-FCF of today is 34.00.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of MiMedx Group was 1721.00. The lowest was 23.00. And the median was 116.67.


MiMedx Group  (NAS:MDXG) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

MiMedx Group's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=4.08/0.12
=34.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of MiMedx Group was 1721.00. The lowest was 23.00. And the median was 116.67.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


MiMedx Group Cyclically Adjusted FCF per Share Related Terms


MiMedx Group Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for MiMedx Group's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MiMedx Group Cyclically Adjusted FCF per Share Chart

MiMedx Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.03 0.05 0.08 0.11

MiMedx Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.09 0.10 0.11 0.12

MDXG vs MNPR, FTH, BBOT: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, MiMedx Group's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MiMedx Group Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MiMedx Group's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where MiMedx Group's Cyclically Adjusted Price-to-FCF falls into.


MDXG
53GF Score
MiMedx Group Inc MDXG
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MiMedx Group Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MiMedx Group's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.009/330.2130*330.2130
=0.009

Current CPI (Mar. 2026) = 330.2130.

MiMedx Group Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.049 241.018 0.067
201609 0.012 241.428 0.016
201612 0.121 241.432 0.165
201703 0.085 243.801 0.115
201706 0.100 244.955 0.135
201709 0.142 246.819 0.190
201712 0.172 246.524 0.230
201803 0.063 249.554 0.083
201806 0.164 251.989 0.215
201809 0.013 252.439 0.017
201812 -0.003 251.233 -0.004
201903 -0.149 254.202 -0.194
201906 0.018 256.143 0.023
201909 -0.030 256.759 -0.039
201912 -0.223 256.974 -0.287
202003 -0.124 258.115 -0.159
202006 -0.032 257.797 -0.041
202009 -0.049 260.280 -0.062
202012 -0.115 260.474 -0.146
202103 -0.079 264.877 -0.098
202106 0.011 271.696 0.013
202109 0.052 274.310 0.063
202112 -0.032 278.802 -0.038
202203 -0.093 287.504 -0.107
202206 -0.030 296.311 -0.033
202209 0.005 296.808 0.006
202212 -0.055 296.797 -0.061
202303 -0.041 301.836 -0.045
202306 0.051 305.109 0.055
202309 0.081 307.789 0.087
202312 0.067 306.746 0.072
202403 0.032 312.332 0.034
202406 0.144 314.175 0.151
202409 0.097 315.301 0.102
202412 0.160 315.605 0.167
202503 0.033 319.799 0.034
202506 0.095 322.561 0.097
202509 0.170 324.800 0.173
202512 0.189 324.054 0.193
202603 0.009 330.213 0.009

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.12 mean?
MiMedx Group (MDXG) has a Cyclically Adjusted FCF per Share of $0.12 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on MiMedx Group and its competitors.
Is MiMedx Group's Cyclically Adjusted FCF per Share too high?
MiMedx Group's current Cyclically Adjusted FCF per Share is $0.12. Overall, MiMedx Group has a GF Score™ of 53/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MiMedx Group's Cyclically Adjusted FCF per Share compare to MNPR and FTH?
MiMedx Group's Cyclically Adjusted FCF per Share of $0.12 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on MiMedx Group and its competitors. MiMedx Group's current Cyclically Adjusted FCF per Share is $0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MiMedx Group stock overvalued right now?
Based on GuruFocus' analysis, MiMedx Group (MDXG) is currently considered Significantly Undervalued. The stock's GF Value™ is $6.87, compared to a current price of $4.08 — trading 40.6% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $0.12. MiMedx Group's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For MiMedx Group (MDXG), the current Cyclically Adjusted FCF per Share is $0.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MiMedx Group (MDXG) Overvalued in 2026?

Based on GuruFocus' analysis, MiMedx Group stock appears to be undervalued. The current stock price of $4.08 is trading 40.6% below its estimated GF Value™ of $6.87. GuruFocus considers MiMedx Group to be Significantly Undervalued.

Key valuation signals for MDXG:

  • Cyclically Adjusted FCF per Share: $0.12
  • GF Value™: $6.87 vs. price of $4.08 (40.6% below fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the MDXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MiMedx Group Business Description

Address 1775 West Oak Commons Court, NE, Marietta, GA, USA, 30062
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
53GF Score

Get the complete analysis for MDXG

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.08
Price
$6.87
GF Value